Phase 2 Trial of Stereotactic Body Radiation Therapy with Dose Escalation Using Simultaneous Integrated Boost for Spinal Metastases
Dose-escalated SIB-SBRT for spinal metastases demonstrates excellent LC with acceptable toxicity, supporting the need for a larger comparative trial.
Authors
- Hiroaki Tanabe (ORCID: https://orcid.org/0000-0003-2424-9460)
- Takahiro Iwai
- Hiroyuki Inoo
- Ryo Ashida (ORCID: https://orcid.org/0000-0001-8388-0135)
- Takamasa Mitsuyoshi (ORCID: https://orcid.org/0000-0001-9983-3106)
- Ryosuke Nasada
- Shigeki Arizono (ORCID: https://orcid.org/0000-0002-8934-4277)
- Toshiyuki Imagumbai
- Peter J. K. Tokuda
- Masaki Kokubo
- Yumi Kokubo
- Mikiko Yamashita
Institutions
- Kyoto University (JP)
- Kobe City Medical Center West Hospital (JP)
- Kitano Hospital (JP)
- Kobe City Medical Center General Hospital (JP)
Publication Details
- Journal
- Advances in Radiation Oncology
- Published
- 2025-04-25
- DOI
- https://doi.org/10.1016/j.adro.2025.101760
- Primary Topic
- Management of metastatic bone disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00